81 FR 79039 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 218 (November 10, 2016)

Page Range		79039-79039
FR Document		2016-27142

Federal Register, Volume 81 Issue 218 (Thursday, November 10, 2016)

[Federal Register Volume 81, Number 218 (Thursday, November 10, 2016)]
[Notices]
[Page 79039]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-27142]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Improved Technologies and Ligands for Non-Invasive 
Brain Imaging (R41/R42).
    Date: November 29, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, National Institute 
on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, 
Bethesda, MD 20892-9550, 301-827-5819, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, R13 Conference Grant Review.
    Date: December 1, 2016.
    Time: 10:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, (301) 827-5820, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: November 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27142 Filed 11-9-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 218 / Thursday, November 10, 2016 / Notices 79039

Place: National Institutes of Health, Name of Committee: National Institute on would constitute a clearly unwarranted
Natcher Building Conference Rooms E1/E2 Drug Abuse Special Emphasis Panel, invasion of personal privacy.
45 Center Drive, Bethesda, MD 20892. Improved Technologies and Ligands for Non-
Contact Person: Mark A. Mueller, Invasive Brain Imaging (R41/R42). Name of Committee: National Institute of
Executive Secretary, AIDS Research Advisory Date: November 29, 2016. Allergy and Infectious Diseases Special
Committee Division of AIDS, NIAID/NIH, Time: 1:00 p.m. to 4:00 p.m. Emphasis Panel, NIAID Clinical Trial
5601 Fishers Lane, RM 8D39, Bethesda, MD Agenda: To review and evaluate grant Implementation Grant (R01).
20892, 301–402–2308, mark.mueller@ applications. Date: November 29, 2016.
nih.gov. Place: National Institutes of Health, Time: 11:00 a.m. to 1:00 p.m.
Neuroscience Center, 6001 Executive Agenda: To review and evaluate grant
Name of Committee: AIDS Research
Boulevard, Rockville, MD 20852 (Telephone applications.
Advisory Committee, NIAID.
Conference Call). Place: National Institutes of Health, 5601
Date: September 11, 2017.
Contact Person: Gerald L. McLaughlin, Fishers Lane, Rockville, MD 20892
Time: 1:00 p.m. to 5:00 p.m.
Ph.D., Scientific Review Officer, Office of (Telephone Conference Call).
Agenda: Reports from the Division Director
Extramural Policy and Review, National Contact Person: Chelsea D. Boyd, Ph.D.,
and other staff.
Institute on Drug Abuse, NIH, DHHS, 6001 Scientific Review Officer, Scientific Review
Place: National Institutes of Health,
Executive Blvd., Room 4238, MSC 9550, Program, DEA/NIAID/NIH/DHHS, 5601
Natcher Building Conference Rooms E1/E2
Bethesda, MD 20892–9550, 301–827–5819, Fishers Lane, MSC–9823, Rockville, MD
45 Center Drive, Bethesda, MD 20892.
gm145a@nih.gov. 20852–9834, 240–669–2081, chelsea.boyd@
Contact Person: Mark A. Mueller,
Name of Committee: National Institute on nih.gov.
Executive Secretary, AIDS Research Advisory
Committee Division of AIDS, NIAID/NIH, Drug Abuse Special Emphasis Panel, R13 Name of Committee: National Institute of
5601 Fishers Lane, RM 8D39, Bethesda, MD Conference Grant Review. Allergy and Infectious Diseases Special
20892, 301–402–2308, mark.mueller@ Date: December 1, 2016. Emphasis Panel, NIAID Clinical Trial
nih.gov. Time: 10:00 a.m. to 12:30 p.m. Implementation Cooperative Agreement
Agenda: To review and evaluate grant (U01).
In the interest of security, NIH has applications. Date: December 5, 2016.
instituted stringent procedures for entrance Place: National Institutes of Health, Time: 11:00 a.m. to 1:00 p.m.
onto the NIH campus. All visitor vehicles, Neuroscience Center, 6001 Executive Agenda: To review and evaluate
including taxicabs, hotel, and airport shuttles Boulevard, Rockville, MD 20852 (Telephone cooperative agreement applications.
will be inspected before being allowed on Conference Call). Place: National Institutes of Health, 5601
campus. Visitors will be asked to show one Contact Person: Hiromi Ono, Ph.D., Fishers Lane, Rockville, MD 20892
form of identification (for example, a Scientific Review Officer, Office of (Telephone Conference Call).
government-issued photo ID, driver’s license, Extramural Affairs, National Institute on Contact Person: Chelsea D. Boyd, Ph.D.,
or passport) and to state the purpose of their Drug Abuse, National Institutes of Health, Scientific Review Officer, Scientific Review
visit. DHHS, 6001 Executive Boulevard, Room Program, DEA/NIAID/NIH/DHHS, 5601
(Catalogue of Federal Domestic Assistance 4238, MSC 9550, Bethesda, MD 20892, (301) Fishers Lane, MSC–9823, Rockville, MD
Program Nos. 93.855, Allergy, Immunology, 827–5820, hiromi.ono@nih.gov. 20852–9834, 240–669–2081, chelsea.boyd@
and Transplantation Research; 93.856, (Catalogue of Federal Domestic Assistance nih.gov.
Microbiology and Infectious Diseases Program Nos.: 93.279, Drug Abuse and
Research, National Institutes of Health, HHS) Name of Committee: National Institute of
Addiction Research Programs, National
Allergy and Infectious Diseases Special
Dated: November 4, 2016. Institutes of Health, HHS)
Emphasis Panel, NIAID Peer Review Meeting.
Natasha M. Copeland, Dated: November 4, 2016. Date: December 7–9, 2016.
Program Analyst, Office of Federal Advisory Natasha M. Copeland, Time: 8:00 a.m. to 5:00 p.m.
Committee Policy. Program Analyst, Office of Federal Advisory Agenda: To review and evaluate contract
[FR Doc. 2016–27139 Filed 11–9–16; 8:45 am] Committee Policy. proposals.
Place: The William F. Bolger Center, 9600
BILLING CODE 4140–01–P [FR Doc. 2016–27142 Filed 11–9–16; 8:45 am] Newbridge Drive, Potomac, MD 20854.
BILLING CODE 4140–01–P Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
DEPARTMENT OF HEALTH AND Program, Division of Extramural Activities,
HUMAN SERVICES DEPARTMENT OF HEALTH AND National Institutes of Health/NIAID, 5601
HUMAN SERVICES Fishers Lane, Room 3F30B, Rockville, MD
National Institutes of Health 20852, 240–669–5029, battlesja@
National Institutes of Health mail.nih.gov.
National Institute on Drug Abuse; Name of Committee: National Institute of
Notice of Closed Meetings National Institute of Allergy and Allergy and Infectious Diseases Special
Infectious Diseases; Notice of Closed Emphasis Panel, NIAID Investigator Initiated
Pursuant to section 10(d) of the Program Project Applications (P01).
Meetings
Federal Advisory Committee Act, as Date: December 7, 2016.
amended (5 U.S.C. App), notice is Pursuant to section 10(d) of the Time: 10:00 a.m. to 2:00 p.m.
hereby given of the following meetings. Federal Advisory Committee Act, as Agenda: To review and evaluate grant
The meetings will be closed to the amended (5 U.S.C. App.), notice is applications.
public in accordance with the hereby given of the following meetings. Place: National Institutes of Health, 5601
provisions set forth in sections The meetings will be closed to the Fishers Lane, Rockville, MD 20892
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the (Telephone Conference Call).
as amended. The grant applications and provisions set forth in sections Contact Person: Raymond R. Schleef,
asabaliauskas on DSK3SPTVN1PROD with NOTICES

the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
confidential trade secrets or commercial as amended. The grant applications and Extramural Activities, Room 3E61, National
property such as patentable material, the discussions could disclose Institutes of Health/NIAID, 5601 Fishers
and personal information concerning confidential trade secrets or commercial Lane, MSC 9823, Bethesda, MD 20892–9823,
individuals associated with the grant property such as patentable material, (240) 669–5019, schleefrr@niaid.nih.gov.
applications, the disclosure of which and personal information concerning Name of Committee: National Institute of
would constitute a clearly unwarranted individuals associated with the grant Allergy and Infectious Diseases Special
invasion of personal privacy. applications, the disclosure of which Emphasis Panel, NIAID Peer Review Meeting.

VerDate Sep<11>2014 17:46 Nov 09, 2016 Jkt 241001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\10NON1.SGM 10NON1

Document Created: 2016-11-10 01:43:34
Document Modified: 2016-11-10 01:43:34

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 29, 2016.
FR Citation		81 FR 79039

81 FR 79039 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 218 (November 10, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health